BeStock  
Stocks › Biotechnology › IMCR

Immunocore IMCR

US equityMarket cap rank #2944Biotechnology
$26.41 −$0.22 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.41 0.00%
Open$26.37
Prev close$26.63
Day range$25.61 – $26.82
Volume546.2K
Market cap$1.36B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

IMCR at a glance

IMCR last changed hands at $26.41 (down 0.83%). At $1.36B, Immunocore is ranked #2944 by size among the 3753 stocks on BeStock.

It is close to the bottom of its 52-week range ($25.61 to $40.71), 35.1% under the high. Holders are behind 32.9% over twelve months, and down 27.9% across the last three months.

On the chart it has slipped under both the 50-day ($30.37) and 200-day ($31.47) moving averages; RSI is 33, and the last 30 sessions moved at roughly 54% annualized volatility.

For the quarter ended Sep 2026 it reported $102.22M in revenue, down 1.4% from a year earlier, and a net loss of $14.22M.

5 analysts follow the stock and the average call is "buy". The mean target, $56.80, sits 115.1% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$25.06 / $30.00
Average price today$26.36
Volume546.2KAvg (90d) 451.3K
Turnover$14.40M
Turnover rate1.19%of shares outstanding
Volume ratio1.77vs. recent average pace
Day amplitude4.53%
Market cap$1.36B
Float market cap$1.21B
Shares outstanding45.99M
EPS (TTM)-$0.71
P/B3.25
Book value / share$8.12
Net profit (TTM)-$36.69M
Net assets$419.70M
30-day volatility53.9%annualized
Avg daily range (ATR)5.75%of price, 14 days
Max drawdown (1y)-34.3%-34.3% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

5 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 17.0 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability29.6
Momentum19.8
Financial health33.7
Analyst view66.8

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$56.80+115.1% vs. current price
Consensus ratingBuy5 analysts covering
Morningstar fair value$28.16Price is below fair value

Wall Street’s average 12-month target is $56.80, 115.1% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $28.16, so shares trade 6.2% below that estimate. On earnings multiple, it sits in the 44th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-0.8%
1 week
-11.8%
1 month
-17.8%
3 months
-27.9%
6 months
-8.4%
Year to date
-23.9%
1 year
-32.9%
Day range
$25.61$26.82
52-week range
$25.61$40.71

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 7 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-11.9%Bearish
Price vs 50-day average-13.0%Bearish
Price vs 200-day average-16.1%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)33.0Bearish
MACD (12,26,9)-0.95Bearish
Bollinger band position2%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How IMCR ranks on BeStock

Market value#2932 of 3734
Closeness to 52-week high#2447 of 3724
Dollar volume today#2205 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

IMCR is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on IMCR.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on IMCR

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

IMCR stock: common questions

What is IMCR's latest share price?

$26.41 is the latest print for IMCR, a move of -0.83% against yesterday's close of $26.63. Today's low and high so far: $25.61 and $26.82.

What is IMCR worth in total?

Equity value comes to $1.36B at the current price. By that measure it is number 2944 of the 3753 names in our coverage.

Is IMCR near its 52-week high or low?

The year's floor is $25.61 and the ceiling $40.71. Shares are 35.1% away from that ceiling.

Does Immunocore pay a dividend?

Our data shows no dividend paid by Immunocore over the trailing twelve months.

Is IMCR rated a buy by Wall Street?

Of 5 analysts, 60% say buy, 40% hold and 0% sell. Price targets average $56.80, with the most cautious at $33.00 and the most optimistic at $80.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on IMCR.

Sign in to join the discussion.

Scroll to Top